SPV-400

N/A

Report date: 2025/05/06 16:25:16
NME

Base Information

Drug NameSPV-400
Drug Alias NameSPV-400
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 stimulants
TargetsNeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSpave Science Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpave Science Inc
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A